Clinical Trial Update: Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients [Phase 2]

View source ↗

Summary

This update reports results from a Phase 2 clinical trial evaluating the effects of fluvastatin on proinflammatory and prothrombotic markers in patients with an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome

Drugs mentioned

• Fluvastatin (fluvastatin)

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Antiphospholipid Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2018-05-01